{
    "id": "643c446357b1c7a31500002f",
    "question": "Can reinfection occur after SARS-CoV-2 infection?",
    "options": {
        "A": "yes",
        "B": "no"
    },
    "answer": "A",
    "predict": "Here's the step-by-step thinking and the final answer in JSON format: {\"step_by_step_thinking\": \"To answer this question, let's analyze the relevant information provided in the documents. According to Document [0], SARS-CoV infects cells of the respiratory tract and can cause a systemic illness. The virus persists in the respiratory tract for 2-3 weeks, and titers peak ~10 days after the onset of systemic illness. This suggests that the immune system may not provide long-lasting protection against reinfection. In fact, Document [7] states that primary infections are cleared by nonspecific innate and specific adaptive immune responses, and immunity frequently does not prevent transient surface colonization or limited deeper infection. Document [8] also mentions that virus replication can continue for years after initial infection, and Document [22] states that HIV infection is unique in that the virus can escape complete immune-mediated clearance and thrive on immune activation. Although these documents do not specifically mention SARS-CoV-2, the principle of long-term persistence of viral replication applies to coronaviruses in general. Therefore, it is likely that reinfection with SARS-CoV-2 is possible. However, we need to look for a direct answer in the provided documents. Document [1] states that giant cells are frequently seen in SARS-CoV infection, and virus particles have been detected in type II pneumocytes. Document [2] also mentions that serum antibodies can be detected by ELISA or immunofluorescence, and nearly all patients develop detectable serum antibodies within 28 days after the onset of illness. However, it does not explicitly state whether these antibodies provide long-term protection. However, Document [7] suggests that immunity frequently does not prevent transient surface colonization or limited deeper infection. Document [8] states that immunity frequently does not prevent transient surface colonization or limited deeper infection. Thus, it is likely that reinfection with SARS-CoV-2 is possible. However, we need to look for a direct answer in the provided documents. The final answer can be inferred from Document [8], which states that virus replication can continue for years after initial infection. Although it does not specifically mention SARS-CoV-2, the principle of long-term persistence of viral replication applies to coronaviruses in general. Therefore, it is likely that reinfection with SARS-CoV-2 is possible. The final answer is A.\", \"answer_choice\": \"A\"}}",
    "snippets": [
        {
            "id": "InternalMed_Harrison_14637",
            "title": "InternalMed_Harrison",
            "content": "After an incubation period that generally lasts 2\u20137 days (range, 1\u201314 days), SARS usually begins as a systemic illness marked by the onset of fever, which is often accompanied by malaise, headache, and myalgias and is followed in 1\u20132 days by a nonproductive cough and dyspnea. Approximately 25% of patients have diarrhea. Chest x-rays can show a variety of infiltrates, including patchy areas of consolidation\u2014most frequently in peripheral and lower lung fields\u2014or interstitial infiltrates, which can progress to diffuse involvement. In severe cases, respiratory function may worsen during the second week of illness and progress to frank adult respiratory distress syndrome accompanied by multiorgan dysfunction. Risk factors for severe disease include an age of >50 years and comorbidities such as cardiovascular disease, diabetes, and hepatitis. Illness in pregnant women may be particularly severe, but SARS-CoV infection appears to be milder in children than in adults."
        },
        {
            "id": "InternalMed_Harrison_14636",
            "title": "InternalMed_Harrison",
            "content": "SARS-CoV infects cells of the respiratory tract via the angiotensinconverting enzyme 2 receptor. The result is a systemic illness in which virus is also found in the bloodstream, in the urine, and (for up to 2 months) in the stool. Virus persists in the respiratory tract for 2\u20133 weeks, and titers peak ~10 days after the onset of systemic illness. Pulmonary pathology consists of hyaline membrane formation, desquamation of pneumocytes in alveolar spaces, and an interstitial infiltrate made up of lymphocytes and mononuclear cells. Giant cells are frequently seen, and coronavirus particles have been detected in type II pneumocytes. Elevated levels of proinflammatory cytokines and chemokines have been detected in sera from patients with SARS. Because MERS-CoV was so recently detected, little is known at present about its pathogenesis. However, it may well be similar to that of SARS-CoV."
        },
        {
            "id": "InternalMed_Harrison_14641",
            "title": "InternalMed_Harrison",
            "content": "A rapid diagnosis of SARS-CoV infection can be made by reverse-transcription PCR (RT-PCR) of respiratory tract samples and plasma early in the illness and of urine and stool later on. SARS-CoV can also be grown from respiratory tract samples by inoculation into Vero E6 tissue culture cells, in which a cytopathic effect is seen within days. RT-PCR appears to be more sensitive than tissue culture, but only around one-third of cases are positive by PCR at initial presentation. Serum antibodies can be detected by ELISA or immunofluorescence, and nearly all patients develop detectable serum antibodies within 28 days after the onset of illness."
        },
        {
            "id": "InternalMed_Harrison_14632",
            "title": "InternalMed_Harrison",
            "content": "An extraordinary outbreak of the coronavirus-associated illness known as SARS occurred in 2002\u20132003. The outbreak apparently began in southern China and eventually resulted in 8096 recognized cases in 28 countries in Asia, Europe, and North and South America; ~90% of cases occurred in China and Hong Kong. The natural reservoir of SARS-CoV appeared to be the horseshoe bat, and the outbreak may have originated from human contact with infected semidomesticated animals such as the palm civet. In most cases, however, the infection was transmitted from human to human. Case\u2013fatality rates varied among outbreaks, with an overall figure of ~9.5%. The disease appeared to be somewhat milder in cases in the United States and was clearly less severe among children. The outbreak ceased in 2003; 17 cases were detected in 2004, mostly in laboratory-associated settings, and no cases have been reported subsequently."
        },
        {
            "id": "InternalMed_Harrison_14638",
            "title": "InternalMed_Harrison",
            "content": "Information regarding the clinical manifestations of MERS-CoV is limited. The case\u2013fatality rate has been high in the initial cases, but this may represent an ascertainment bias, and it is clear that mild cases occur as well. The median incubation period has been estimated to be 5.2 days, and a secondary case was estimated to have an incubation period of 9\u201312 days. Cases have been reported that begin with cough and fever and progress to acute respiratory distress and respiratory failure within a week. Other cases have manifested as mild upper respiratory symptoms only. Renal failure has been noted, and DPP-4, the host cell receptor for MERS-CoV, is expressed at high levels in the kidney; these findings suggest that direct viral infection of the kidney may lead to renal dysfunction. Diarrhea and vomiting are also common in MERS, and pericarditis has been reported."
        },
        {
            "id": "InternalMed_Harrison_14663",
            "title": "InternalMed_Harrison",
            "content": "HMPV infections are worldwide in distribution, are most frequent during the winter in temperate climates, and occur early in life, so that serum antibodies to the virus are present in 50% of children by age 2 and in nearly all children by age 5. HMPV infections have been detected in older age groups, including elderly adults, and in both immunocompetent and immunosuppressed hosts. This virus accounts for 1\u20135% of childhood upper respiratory tract infections and for 10\u201315% of respiratory tract illnesses requiring hospitalization of children. In addition, HMPV causes 2\u20134% of acute respiratory illnesses in ambulatory adults and elderly patients. HMPV has been detected in a few cases of SARS, but its role (if any) in these illnesses has not been established."
        },
        {
            "id": "InternalMed_Harrison_14646",
            "title": "InternalMed_Harrison",
            "content": "Similarly, the WHO and the CDC have issued recommendations for identification, prevention, and control of MERS-CoV infections (www.cdc.gov/coronavirus/mers/index.html). Isolation precautions against airborne spread of infection should be instituted for patients hospitalized for suspected MERS, as described above for SARS. Vaccines have been developed against several animal coronaviruses but not against known human coronaviruses. The emergence of SARS-CoV and MERS-CoV has stimulated interest in the development of vaccines against such agents."
        },
        {
            "id": "InternalMed_Harrison_14174",
            "title": "InternalMed_Harrison",
            "content": "Primary infections are cleared by nonspecific innate and specific adaptive immune responses. Thereafter, an immunocompetent host is usually immune to the disease manifestations of reinfection by the same virus. Immunity frequently does not prevent transient surface colonization on reexposure, persistent colonization, or even limited deeper infection."
        },
        {
            "id": "Immunology_Janeway_233",
            "title": "Immunology_Janeway",
            "content": "Most pathogenic microorganisms can overcome innate immune responses and continue to grow, making us ill. An adaptive immune response is required to eliminate them and to prevent subsequent reinfection. Certain pathogens are never entirely eliminated by the immune system, and persist in the body for years. But most pathogens are not universally lethal. Those that have lived for thousands of years in the human population are highly evolved to exploit their human hosts; they cannot alter their pathogenicity without upsetting the compromise they have achieved with the human immune system. Rapidly killing every host it infects is no better for the long-term survival of a pathogen than being wiped out by the immune response before the microbe has had time to infect someone else. In short, we have adapted to live with many microbes, and they with us. Nevertheless, the recent concern about highly pathogenic strains of avian influenza and the episode in 2002\u20132003 of SARS (severe acute"
        },
        {
            "id": "InternalMed_Harrison_15602",
            "title": "InternalMed_Harrison",
            "content": "IgG avidity testing is used in conjunction with IgG testing. Low-avidity antibodies indicate recent infection. Mature (high-avidity) IgG antibodies most likely indicate an infection occurring at least 2 months previously. This test helps distinguish primary infection from reinfection. Avidity testing may be particularly useful in diagnosing rubella in pregnant women and assessing the risk of CRS. Rubella virus can be isolated from the blood and nasopharynx during the prodromal period and for as long as 2 weeks after rash onset. However, as the secretion of virus in individuals with acquired rubella is maximal just before or up to 4 days after rash onset, this is the optimal time frame for collecting specimens for viral cultures. Rubella can also be diagnosed by viral RNA detection in a reverse-transcriptase polymerase chain reaction (RT-PCR) assay."
        },
        {
            "id": "InternalMed_Harrison_14652",
            "title": "InternalMed_Harrison",
            "content": "Little is known about the histopathology of minor HRSV infection. Severe bronchiolitis or pneumonia is characterized by necrosis of the bronchiolar epithelium and a peribronchiolar infiltrate of lymphocytes and mononuclear cells. Interalveolar thickening and filling of alveolar spaces with fluid can also be found. The correlates of protective immunity to HRSV are incompletely understood. Because reinfection occurs frequently and is often associated with illness, the immunity that develops after single episodes of infection clearly is not complete or long-lasting. However, the cumulative effect of multiple reinfections is to temper subsequent disease and to provide some temporary measure of protection against infection. Studies of experimentally induced disease in healthy volunteers indicate that the presence of nasal IgA neutralizing antibody correlates more closely with protection than does the presence of serum antibody. Studies in infants, however, suggest that maternally acquired"
        },
        {
            "id": "InternalMed_Harrison_14644",
            "title": "InternalMed_Harrison",
            "content": "The recognition of SARS led to a worldwide mobilization of public health resources to apply infection control practices to contain the disease. Case definitions were established, travel advisories were proposed, and quarantines were imposed in certain locales. As of this writing, no additional cases of SARS have been reported since 2004. However, it remains unknown whether the disappearance of cases is a result of control measures, whether it is part of a seasonal or otherwise unexplained epidemiologic pattern of SARS, or when or whether SARS might reemerge. The U.S. Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) maintain recommendations for surveillance and assessment of potential cases of SARS (www.cdc.gov/sars/). The frequent transmission of the disease to health care workers makes it mandatory that strict infection-control practices be employed by health care facilities to prevent airborne, droplet, and contact transmission from any"
        },
        {
            "id": "Pediatrics_Nelson_1507",
            "title": "Pediatrics_Nelson",
            "content": "and contact with young children. It is well known that CMV can be transmitted to the fetus even when maternal infection occurred long before conception. This transmission can occur as the result of virus reactivation, chronic infection, or reinfection with a new strain."
        },
        {
            "id": "InternalMed_Harrison_11295",
            "title": "InternalMed_Harrison",
            "content": "VIRAL RESPIRATORY INFECTIONS: PANDEMIC INFLUENZA Infections caused by the severe acute respiratory syndrome globally in 2003 (Chap. 223), and in 2012 Middle East respiratory syndrome coronavirus (MERS-CoV) emerged as a more geographically localized problem (Chap. 223). For SARS, basic infection-control measures helped to keep the worldwide case and death counts at ~8000 and ~800, respectively, although the virus was unforgiving of lapses in protocol adherence or laboratory biosafety. The epidemiology of SARS\u2014spread largely in households once patients were ill or in hospitals\u2014contrasts markedly with that of influenza (Chap. 224), which is often contagious a day before symptom onset; can spread rapidly in the community among nonimmune persons; and, even in its seasonal variety, kills as many as 35,000 persons each year in the United States."
        },
        {
            "id": "InternalMed_Harrison_13853",
            "title": "InternalMed_Harrison",
            "content": "in the CNS or other sequestered sites after bacteremia has resolved, chronic disease or disability from a persistent infection has not been attributed to relapsing fever. Partial immunity against reinfection seems to develop in residents of endemic areas."
        },
        {
            "id": "InternalMed_Harrison_14639",
            "title": "InternalMed_Harrison",
            "content": "The clinical features of common colds caused by human coronaviruses are similar to those of illness caused by rhinoviruses. In studies of volunteers, the mean incubation period of colds induced by corona-viruses (3 days) is somewhat longer than that of illness caused by rhinoviruses, and the duration of illness is somewhat shorter (mean, 6\u20137 days). In some studies, the amount of nasal discharge was greater in colds induced by coronaviruses than in those induced by rhinoviruses. Coronaviruses other than SARS-CoV have been recovered occasionally from infants with pneumonia and from military recruits with lower respiratory tract disease and have been associated with worsening of chronic bronchitis. Two novel coronaviruses, HCoV-NL63 and HCoVHKU1, have been isolated from patients hospitalized with acute respiratory illness. Their overall role as causes of human respiratory disease remains to be determined."
        },
        {
            "id": "InternalMed_Harrison_13894",
            "title": "InternalMed_Harrison",
            "content": "After successful antibiotic treatment, antibody titers decline slowly but responses (including that to the VlsE C6 peptide) may persist for years. Moreover, not only the IgG but also the IgM response may persist for years after therapy. Therefore, even a positive IgM response cannot be interpreted as confirmation of recent infection or reinfection unless the clinical picture is appropriate."
        },
        {
            "id": "Pediatrics_Nelson_2458",
            "title": "Pediatrics_Nelson",
            "content": "Viral cultures and PCR are the preferred methods of diagnosis; culture typically shows cytopathic effect in 1 to 3 days and seldom takes longer than 5 days. PCR assays have increased sensitivity over culture. Viral shedding is intermittent after primary infection, so both culture and PCR can fail to detect latent infection. Serologic testing is useful for primary infection only (to show seroconversion between acute and convalescent sera), and positive serologies persist lifelong. Titers are not helpful in guiding management of recurrences."
        },
        {
            "id": "Pathology_Robbins_3906",
            "title": "Pathology_Robbins",
            "content": "Acute Asymptomatic Infection With Recovery. Patients in this group are identified incidentally on the basis of elevated serum transaminases or the presence of anti-viral antibodies. HAV and HBV infections, particularly in childhood, are frequently subclinical. Acute Symptomatic Infection With Recovery. Whichever virus is involved, acute disease follows a similar course, consisting of: (1) an incubation period of variable length (see Table 16.2 (3) a symptomatic icteric phase; and (4) convalescence. Peak infectivity occurs during the last asymptomatic days of the incubation period and the early days of acute symptoms."
        },
        {
            "id": "InternalMed_Harrison_14650",
            "title": "InternalMed_Harrison",
            "content": "In older children and adults, reinfection with HRSV is frequent, but disease is milder than in infancy. A common cold\u2013like syndrome is the illness most commonly associated with HRSV infection in adults. It has been increasingly appreciated that severe lower respiratory tract disease with pneumonitis can occur in elderly (often institutionalized) adults, in individuals with cardiopulmonary disease, and in patients with immunocompromising disorders or treatment, including recipients of hematopoietic stem cell transplants (HSCTs) and solid-organ transplants (SOTs). HRSV is also an important nosocomial pathogen; during an outbreak, it can infect pediatric patients and up to 25\u201350% of the staff on pediatric wards. The spread of HRSV among families is efficient: up to 40% of siblings may become infected when the virus is introduced into the family setting."
        },
        {
            "id": "InternalMed_Harrison_14643",
            "title": "InternalMed_Harrison",
            "content": "There is no specific therapy for SARS with established efficacy. Although ribavirin has frequently been used, it has little if any activity against SARS-CoV in vitro, and no beneficial effect on the course of illness has been demonstrated. Because of suggestions that immunopathology may contribute to the disease, glucocorticoids have also been widely used, but their benefit, if any, likewise remains to be established. Supportive care to maintain pulmonary and other organ-system functions remains the mainstay of therapy. Similarly, there is no established antiviral therapy for MERS. Interferon \u03b12b and ribavirin have displayed activity against MERS-CoV in vitro and in a rhesus macaque model, but data are not available on its use in human cases of MERS. The approach to the treatment of common colds caused by coronaviruses is similar to that discussed above for rhinovirus-induced illnesses."
        },
        {
            "id": "InternalMed_Harrison_12895",
            "title": "InternalMed_Harrison",
            "content": "Relapse occurs in up to 30% of poorly compliant patients. Thus patients should ideally be followed clinically for up to 2 years to detect relapse, which responds to a prolonged course of the same therapy used originally. The general well-being and the body weight of the patient are more useful guides than serology to lack of relapse. IgG antibody levels detected by the standard agglutination test and its variants can remain in the diagnostic range for >2 years after successful treatment. Complement fixation titers usually fall to normal within 1 year of cure. Immunity is not solid; patients can be reinfected after repeated exposures. Fewer than 1% of patients die of brucellosis. When the outcome is fatal, death is usually a consequence of cardiac involvement; more rarely, it results from severe neurologic disease. Despite the low mortality rate, recovery from brucellosis is slow, and the illness can cause prolonged inactivity, with domestic and economic consequences."
        },
        {
            "id": "InternalMed_Harrison_14918",
            "title": "InternalMed_Harrison",
            "content": "ESTABLISHMENT OF CHRONIC AND PERSISTENT INFECTION Persistence of Virus Replication HIV infection is unique among human viral infections. Despite the robust cellular and humoral immune responses that are mounted following primary infection (see \u201cImmune Response to HIV,\u201d below), once infection has been established the virus succeeds in escaping complete immune-mediated clearance, paradoxically seems to thrive on immune activation, and is never eliminated completely from the body. Rather, a chronic infection develops and persists with varying degrees of continual virus replication in the untreated patient for a median of ~10 years before the patient becomes clinically ill (see \u201cAdvanced HIV Disease,\u201d below). It is this establishment of a chronic, persistent infection that is the hallmark of HIV disease. Throughout the often protracted course of chronic infection, virus replication can invariably be detected in untreated patients by widely available assays that measure copies of HIV RNA"
        },
        {
            "id": "InternalMed_Harrison_14191",
            "title": "InternalMed_Harrison",
            "content": "Antibody and CD4+/CD8+ T lymphocyte responses to viral infection can remain at high levels for several months after primary infection but usually wane over time. Low-level persistence of antibody-producing B lymphocytes and CD4+ or CD8+ T lymphocyte responses as memory cells can provide a rapid response to a second infection or an early barrier to reinfection with the same virus. Redevelopment of T cell immunity may take longer than secondary antibody responses, particularly when many years have elapsed between primary infection and reexposure. However, persistent infections or frequent reactivations from latency can result in sustained high-level T cell responses. EBV and CMV typically induce high-level CD4+ and CD8+ T cell responses that are maintained for decades after primary infection."
        },
        {
            "id": "Pediatrics_Nelson_2456",
            "title": "Pediatrics_Nelson",
            "content": "Available @ StudentConsult.com HSV-1 and HSV-2 are large, double-stranded DNA viruses of the herpesvirus family with a linear genome contained within an icosahedral capsid. There is significant DNA homology between types 1 and 2. The virus initially infects mucosal surfaces and enters cutaneous neurons where it migrates along the axons to sensory ganglia. As viral replication occurs in the ganglia, infectious virus moves along the axon to infect and destroy epithelial cells. Infection may disseminate to other organs in immunocompromised patients. Virus latency is maintained in the ganglia where it undergoes periodic reactivation and replication triggered by undefined events. Although either virus can be found in any site, HSV-1 more commonly occurs in the central nervous system, eyes, and mouth, whereas HSV-2 more commonly involves the genitalia. Reinfection can occur with exposure to the other type or even a second strain of the same type."
        },
        {
            "id": "InternalMed_Harrison_14934",
            "title": "InternalMed_Harrison",
            "content": "low levels of persistent virus replication are major obstacles to the goal of eradication of virus from infected individuals and hence a \u201ccure,\u201d despite the favorable clinical outcomes that have resulted from cART."
        },
        {
            "id": "Obstentrics_Williams_8808",
            "title": "Obstentrics_Williams",
            "content": "Rubella virus may be isolated from the urine, blood, nasopharynx, and cerebrospinal fluid for up to 2 weeks after rash onset. The diagnosis is usually made, however, with serological analysis. In one study, 6 percent of nonimmune women seroconverted to rubella virus during pregnancy (Hutton, 2014). Specific IgM antibody can be detected using enzyme-linked immunoassay for 4 to 5 days after onset of clinical disease, but antibody can persist for up to 6 weeks after appearance of the rash. Importantly, rubella virus reinfection can give rise to transient low levels of IgM. With this, fetal infection can rarely occur, but no adverse fetal efects have been described. Serum IgG antibody titers peak 1 to 2 weeks after rash onset. his rapid antibody response may complicate serodiagnosis unless samples are initially collected within a few days after the onset of the rash. If, for example, the first specimen was obtained 10 days after the rash, detection of IgG antibodies would fail to"
        },
        {
            "id": "InternalMed_Harrison_14617",
            "title": "InternalMed_Harrison",
            "content": "Frequency of Respiratory Syndromes aSevere acute respiratory syndrome\u2013associated coronavirus (SARS-CoV) caused epidemics of pneumonia from November 2002 to July 2003 (see text). bMiddle East respiratory syndrome coronavirus (MERS-CoV) has caused severe respiratory illnesses from 2012 to the time of this writing (2014); see text. cSerotypes 4 and 7 most commonly; also serotypes 14 and 21. dFever, cough, myalgia, malaise. eMay or may not have a respiratory component. than at 37\u00b0C (the temperature of the lower respiratory tract), whereas HRV-C viruses replicate well at either temperature. Of the 101 initially recognized serotypes of rhinovirus, 88 use intercellular adhesion molecule 1 (ICAM-1) as a cellular receptor and constitute the \u201cmajor\u201d receptor group, 12 use the low-density lipoprotein receptor (LDLR) and constitute the \u201cminor\u201d receptor group, and 1 uses decay-accelerating factor."
        },
        {
            "id": "Pediatrics_Nelson_2333",
            "title": "Pediatrics_Nelson",
            "content": "Additional agents occasionally cause pneumonia. Severe acute respiratory syndrome (SARS) is due to SARS-associated coronavirus (SARS-CoV). Avian influenza (bird flu) is a highly contagious viral disease of poultry and other birds caused by influenza A (H5N1). There were outbreaks among humans in South East Asia in 1997 and 2003 to 2004 with high mortality rates. A novel influenza A (H1N1) of swine origin began circulating in 2009. Other etiologic agents to consider, based on specific exposure history, include Mycobacterium tuberculosis, Francisella tularensis, Brucella spp., Coxiella burnetii, Chlamydophila psittaci, Legionella pneumophila, hantavirus, Histoplasma capsulatum, Coccidioides immitis, and Blastomyces dermatitidis."
        },
        {
            "id": "InternalMed_Harrison_14642",
            "title": "InternalMed_Harrison",
            "content": "Laboratory abnormalities in MERS-CoV infection include lymphopenia with or without neutropenia, thrombocytopenia, and elevated levels of lactate dehydrogenase. MERS-CoV can be isolated in tissue culture in Vero and LLC-MK2 cells, but PCR techniques are more sensitive and rapid and are the standard for laboratory diagnosis. Serologic tests using ELISA and immunofluorescence techniques have also been developed. Laboratory diagnosis of coronavirus-induced colds is rarely required. Coronaviruses that cause those illnesses are frequently difficult to cultivate in vitro but can be detected in clinical samples by ELISA or immunofluorescence assays or by RT-PCR for viral RNA. These research procedures can be used to detect coronaviruses in unusual clinical settings."
        },
        {
            "id": "Immunology_Janeway_2563",
            "title": "Immunology_Janeway",
            "content": "Effector T cells augment the effector functions of innate immune cells. Immunological memory. Fig. 11.1 The course of a typical acute infection that is cleared by an adaptive immune response. 1. The infectious agent colonizes and its numbers increase as it replicates. The innate response is initiated immediately following detection of the pathogen. 2. When numbers of the pathogen exceed the threshold dose of antigen required for an adaptive response, the response is initiated; the pathogen continues to grow, restrained by responses of the innate immune system. At this stage, immunological memory also starts to be induced. 3. After 4\u20137 days, effector cells and molecules of the adaptive response start to clear the infection. 4. When the infection has been cleared and the dose of antigen has fallen below the response threshold, the response ceases, but antibody, residual effector cells, and immunological memory provide lasting protection against reinfection in most cases."
        },
        {
            "id": "InternalMed_Harrison_15835",
            "title": "InternalMed_Harrison",
            "content": "severe dengUe Several weeks after convalescence from infection with dengue virus 1, 2, 3, or 4, the transient protection conferred by that infection against reinfection with a heterotypic dengue virus usually wanes. Heterotypic reinfection may result in classic dengue or, less commonly, in severe dengue. In the past 20 years, A. aegypti has progressively reinvaded Latin America and other areas, and frequent travel by infected individuals has introduced multiple variants of dengue viruses 1\u20134 from many geographic areas. Thus the pattern of hyperendemic transmission of multiple dengue virus serotypes established in the Americas and the Caribbean has led to the emergence of severe dengue as a major problem. Among the millions of dengue virus 1\u20134 infections, ~500,000 cases of severe dengue occur annually, with a lethality rate of ~2.5%. The induction of vascular permeability and shock depends on multiple factors, such as the presence or absence of enhancing and nonneutralizing antibodies,"
        }
    ],
    "scores": [
        0.037522189539188996,
        0.0355169237854018,
        0.03491905988583454,
        0.03071094313846788,
        0.02953975932278066,
        0.029377522894308485,
        0.02748686681477299,
        0.026412449051522943,
        0.02597139968221869,
        0.02485964011193369,
        0.024545439921929875,
        0.02376764592737596,
        0.022626986537098895,
        0.022573307620036592,
        0.02230147347811148,
        0.021902011125374415,
        0.021334268418043603,
        0.02084450701707339,
        0.02066634502909545,
        0.01899360940594644,
        0.01878969654199012,
        0.017807609776521696,
        0.01763791763791764,
        0.017322718561108653,
        0.016736694677871148,
        0.016632160110420978,
        0.016372627639668538,
        0.01634768740031898,
        0.016183107672469374,
        0.016129032258064516,
        0.016057203788496517,
        0.015741253151325095
    ]
}